Skip to main content
ALLERGY THERAPEUTICS PLC logo

ALLERGY THERAPEUTICS PLC — Investor Relations & Filings

Ticker · AGY ISIN · GB00B02LCQ05 LEI · 213800PQ7AHK7KGVOE23 IL Manufacturing
Open in API
Filings indexed 416 across all filing types
Latest filing 2016-09-20 Share Issue/Capital Cha…
Country GB United Kingdom
Listing IL AGY

About ALLERGY THERAPEUTICS PLC

https://allergytherapeutics.com/

Allergy Therapeutics PLC is an immunology company focused on the research, development, diagnosis, and treatment of allergic disorders. The company specializes in creating therapies for allergy treatment and prevention, with a key focus on developing aluminum-free immunotherapies and allergy vaccines. These treatments aim to address the underlying cause of the allergy rather than merely managing symptoms. Leveraging its specialist expertise in immunology, the company strives to develop effective and convenient solutions to improve the quality of life for individuals with allergies.

Recent filings

Filing Released Lang Actions
Issue of equity in respect of exercise of options
Share Issue/Capital Change Classification · 98% confidence The document is identified by the 'RNS Number' header and explicitly states 'This information is provided by RNS The company news service from the London Stock Exchange'. The content details the 'Issue of equity in respect of the exercise of options' and the subsequent application for admission to trading on AIM. This is a specific corporate action announcement related to share capital changes, which strongly aligns with the 'Share Issue/Capital Change' definition (SHA). Although it is an RNS announcement, SHA is a more specific category than the general RNS fallback, and the core subject is a share issue.
2016-09-20 English
Notice of Preliminary Results
Report Publication Announcement Classification · 99% confidence The document is very short (2194 characters) and its primary purpose is to announce *when* the preliminary results for the twelve-month period ended 30 June 2016 will be issued (Monday 26 September 2016). It also mentions a subsequent presentation/conference call. This structure—announcing the publication date of a report rather than containing the full report itself—fits the definition of a Report Publication Announcement (RPA). It is not the actual Earnings Release (ER) or the full Annual Report (10-K). The presence of the RNS Number further confirms it is a regulatory announcement, but RPA is more specific for announcing the release of other reports.
2016-09-05 English
Trading Update
Earnings Release Classification · 98% confidence The document is identified by the 'RNS Number' header and the closing statement 'This information is provided by RNS The company news service from the London Stock Exchange'. The content is a 'Trading Update' providing preliminary financial figures (£48.5m revenue vs £43.2m prior year) and pipeline progress ahead of the full 'Preliminary Results to be announced in September 2016'. Since this is an early announcement of key financial highlights and business updates, it fits the definition of an Earnings Release (ER). It is not the full report (10-K or IR), nor is it a transcript (CT) or a formal presentation (IP). The document explicitly states it contains 'inside information' under EU regulation, typical for market-sensitive updates. FY 2016
2016-07-13 English
Findings from mEEC dose range finding study G204
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated June 27, 2016. It announces findings from a clinical study (G204) for a drug program (GrassMATAMPL) and provides updates on European sales and pipeline progress. The content is a formal announcement of operational and clinical development news, not a full financial report (like 10-K or IR) or a transcript. Since it is a general regulatory announcement disseminated via the RNS service and covers operational updates that don't fit perfectly into specific categories like ER, CAP, or LTR, the most appropriate classification is the general regulatory filing category, RNS, as it is explicitly sourced from the 'company news service from the London Stock Exchange'. The document length (5088 chars) is substantial enough that it is the primary announcement, not just a notice of publication (RPA).
2016-06-27 English
Appointment of Finance Director
Board/Management Information Classification · 98% confidence The document is a formal announcement disseminated via the RNS (Regulatory News Service) number 8031A, dated June 10, 2016. The core content announces the 'Appointment of Finance Director' (Nick Wykeman) and the resignation of the previous director. This type of announcement, detailing changes in senior management or the board of directors, directly corresponds to the definition for Board/Management Information (MANG). Although it is distributed via RNS, the specific subject matter is management change, making MANG the most precise classification over the general RNS fallback.
2016-06-10 English
Positive Phase II Data
Regulatory Filings Classification · 95% confidence The document begins with an 'RNS Number' and is dated May 9, 2016. The content announces 'positive top-line results' from a Phase II clinical study (PQBirch204) for a pharmaceutical product. This is a typical structure for a company press release announcing significant operational or clinical milestones. Since it is a general announcement of results, it fits best under 'Earnings Release' (ER) if it were financial results, but since it is clinical trial results, it is a specific type of corporate news. Given the options, it is a general regulatory announcement disseminated via RNS. It is not a full Annual Report (10-K), a formal Audit Report (AR), or a specific financial filing like MRQ or DIV. It is a news announcement, and the presence of the 'RNS Number' and the closing 'This information is provided by RNS' strongly suggests it is a general regulatory filing that doesn't fit a more specific category like ER (which usually covers financial performance). Therefore, the most appropriate fallback category is Regulatory Filings (RNS). The document length (5948 chars) is substantial enough that it is the announcement itself, not just a notice that a report is attached (which would suggest RPA).
2016-05-09 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.